RXST RSI Chart
Last 7 days
2.9%
Last 30 days
-11.6%
Last 90 days
22.5%
Trailing 12 Months
225%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 57.6M | 67.0M | 76.6M | 89.1M |
2022 | 28.1M | 34.5M | 41.3M | 49.0M |
2021 | 16.7M | 18.6M | 20.6M | 22.6M |
2020 | 0 | 0 | 0 | 14.7M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 01, 2024 | thunen shelley b | sold | -563,726 | 56.3726 | -10,000 | chief financial officer |
Mar 01, 2024 | thunen shelley b | acquired | 155,983 | 15.5983 | 10,000 | chief financial officer |
Feb 16, 2024 | goldshleger ilya | acquired | 230,400 | 23.04 | 10,000 | chief operating officer |
Feb 16, 2024 | goldshleger ilya | sold | -555,000 | 55.5 | -10,000 | chief operating officer |
Feb 15, 2024 | goldshleger ilya | sold | -535,000 | 53.5 | -10,000 | chief operating officer |
Feb 15, 2024 | goldshleger ilya | acquired | 230,400 | 23.04 | 10,000 | chief operating officer |
Feb 14, 2024 | tammenoms bakker juliet | bought | 205,153 | 51.2883 | 4,000 | - |
Feb 14, 2024 | goldshleger ilya | sold | -260,000 | 52.00 | -5,000 | chief operating officer |
Feb 14, 2024 | goldshleger ilya | acquired | 115,200 | 23.04 | 5,000 | chief operating officer |
Feb 12, 2024 | tammenoms bakker juliet | bought | 201,520 | 50.3799 | 4,000 | - |
Which funds bought or sold RXST recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 11, 2024 | VANGUARD GROUP INC | added | 3.49 | 19,842,300 | 59,835,300 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 200 | 5,965,970 | 7,753,050 | -% |
Mar 01, 2024 | READYSTATE ASSET MANAGEMENT LP | new | - | 728,179 | 728,179 | 0.03% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | added | 4.5 | 192,646 | 569,802 | -% |
Feb 16, 2024 | GSA CAPITAL PARTNERS LLP | sold off | -100 | -628,000 | - | -% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | added | 131 | 1,693,000 | 2,417,000 | -% |
Feb 15, 2024 | Circle Wealth Management, LLC | unchanged | - | 2,059,890 | 6,681,790 | 0.17% |
Feb 15, 2024 | Farther Finance Advisors, LLC | reduced | -90.00 | -955 | 161 | -% |
Feb 15, 2024 | Legal & General Group Plc | added | 20.5 | 370,063 | 868,735 | -% |
Feb 15, 2024 | JANE STREET GROUP, LLC | new | - | 2,770,190 | 2,770,190 | -% |
Unveiling RxSight, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to RxSight, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 196.9B | 40.1B | 34.4 | 4.91 | ||||
BDX | 71.2B | 19.5B | 56.69 | 3.65 | ||||
ALGN | 24.6B | 3.9B | 55.33 | 6.38 | ||||
BAX | 21.7B | 14.8B | 8.16 | 1.46 | ||||
MID-CAP | ||||||||
BIO | 10.2B | 2.7B | -16.04 | 3.83 | ||||
HSIC | 9.7B | 12.3B | 23.21 | 0.78 | ||||
ATR | 9.5B | 3.5B | 33.57 | 2.74 | ||||
XRAY | 6.9B | 4.0B | -51.36 | 1.74 | ||||
AXNX | 3.5B | 366.4M | -577.22 | 9.59 | ||||
PDCO | 2.5B | 6.6B | 12.86 | 0.38 | ||||
SMALL-CAP | ||||||||
AHCO | 1.5B | 3.2B | -2.23 | 0.47 | ||||
ANIK | 379.3M | 166.7M | -4.59 | 2.28 | ||||
ANGO | 227.2M | 329.5M | -16.09 | 0.69 | ||||
APYX | 43.3M | 52.3M | -2.31 | 0.83 | ||||
AEMD | 4.5M | 3.7M | -0.37 | 1.19 |
RxSight, Inc. News
Income Statement (Quarterly) | ||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 |
Revenue | 28.7% | 28,579,500 | 22,199,000 | 20,810,000 | 17,489,000 | 16,088,000 | 12,615,000 | 11,360,000 | 8,942,000 | 8,426,000 | 5,786,000 | 4,897,000 | 3,484,000 | 3,827,000 | 4,170,000 | 2,706,000 |
Gross Profit | 28.6% | 17,653,500 | 13,731,000 | 12,015,000 | 10,366,000 | 7,422,500 | 5,356,000 | 4,788,000 | 3,761,000 | 2,869,000 | 1,341,000 | -812,000 | 1,119,000 | - | 720,000 | -474,000 |
Operating Expenses | 8.6% | 28,505,000 | 26,243,000 | 25,640,000 | 23,463,000 | 22,412,500 | 21,314,000 | 20,580,000 | 20,339,000 | 17,532,000 | 14,453,000 | 13,065,000 | 12,254,000 | - | 9,626,000 | 8,333,000 |
S&GA Expenses | 10.6% | 21,164,000 | 19,142,000 | 18,239,000 | 16,255,000 | 15,731,000 | 14,926,000 | 14,388,000 | 13,620,000 | 11,616,000 | 9,076,000 | 6,502,000 | 5,611,000 | - | 3,825,000 | 3,249,000 |
R&D Expenses | 3.4% | 7,341,000 | 7,101,000 | 7,401,000 | 7,208,000 | 6,681,500 | 6,388,000 | 6,192,000 | 6,719,000 | 5,916,000 | 5,377,000 | 6,563,000 | 6,643,000 | - | 5,801,000 | 5,084,000 |
EBITDA Margin | 23.5% | -0.46 | -0.60 | -0.74 | -0.92 | -1.18 | -1.41 | -1.57 | -1.83 | -1.82 | 1.55 | 1.72 | 1.92 | - | - | - |
Interest Expenses | -98.5% | 3,500 | 230,000 | 1,568,000 | 1,507,000 | 1,451,000 | 1,299,000 | 1,136,000 | 1,060,000 | 1,079,000 | 1,079,000 | 826,000 | 698,000 | - | 3,000 | 4,000 |
Income Taxes | -250.0% | -18,000 | 12,000 | 26,000 | - | 5,000 | - | - | 4,000 | 2,000 | -4,000 | 3,000 | 7,000 | - | 8,000 | 40,000 |
Earnings Before Taxes | 25.9% | -9,195,000 | -12,403,000 | -13,778,000 | -13,212,000 | -15,605,000 | -16,818,000 | -16,732,000 | -17,592,000 | -15,731,500 | -12,677,000 | -13,474,000 | -6,798,000 | - | 30,672,000 | -12,842,000 |
EBT Margin | 24.0% | -0.55 | -0.72 | -0.89 | -1.08 | -1.36 | -1.62 | -1.82 | -2.12 | -2.15 | 1.34 | 1.48 | 1.66 | - | - | - |
Net Income | 26.1% | -9,177,000 | -12,415,000 | -13,804,000 | -13,212,000 | -15,610,000 | -16,818,000 | -16,732,000 | -17,596,000 | -15,733,500 | -12,673,000 | -13,477,000 | -6,805,000 | 26,295,000 | 30,664,000 | -12,882,000 |
Net Income Margin | 24.1% | -0.55 | -0.72 | -0.89 | -1.08 | -1.36 | -1.62 | -1.82 | -2.12 | -2.16 | -0.32 | 1.97 | 2.24 | - | - | - |
Free Cashflow | -14.6% | -9,892,000 | -8,635,000 | -9,369,000 | -18,511,000 | -14,216,000 | -15,768,000 | -15,904,000 | -15,355,000 | -9,087,000 | -14,009,000 | -12,802,000 | -10,750,000 | - | - | - |
Balance Sheet | |||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2020Q4 |
Assets | 0.4% | 183 | 182 | 195 | 203 | 150 | 156 | 167 | 177 | 193 | 204 | 95.00 | 101 |
Current Assets | 0.3% | 168 | 168 | 180 | 188 | 135 | 139 | 150 | 161 | 176 | 186 | 76.00 | 82.00 |
Cash Equivalents | -1.7% | 10.00 | 10.00 | 9.00 | 11.00 | 12.00 | 10.00 | 25.00 | 25.00 | 25.00 | 69.00 | 42.00 | 14.00 |
Inventory | -7.9% | 17.00 | 19.00 | 18.00 | 18.00 | 15.00 | 15.00 | 12.00 | 8.00 | 8.00 | 9.00 | 9.00 | 8.00 |
Net PPE | 5.6% | 11.00 | 10.00 | 11.00 | 10.00 | 10.00 | 11.00 | 11.00 | 11.00 | 11.00 | 12.00 | 13.00 | 13.00 |
Liabilities | 8.9% | 22.00 | 20.00 | 38.00 | 58.00 | 60.00 | 60.00 | 57.00 | 54.00 | 54.00 | 53.00 | 55.00 | 45.00 |
Current Liabilities | 10.4% | 21.00 | 19.00 | 17.00 | 15.00 | 17.00 | 16.00 | 13.00 | 11.00 | 11.00 | 9.00 | 11.00 | 12.00 |
Long Term Debt | - | - | - | 20.00 | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 | 24.00 |
Shareholder's Equity | -0.7% | 160 | 161 | 157 | 145 | 90.00 | 96.00 | 110 | 123 | 138 | 151 | - | - |
Retained Earnings | -1.6% | -594 | -585 | -573 | -559 | -546 | -530 | -513 | -496 | -479 | -463 | -450 | -430 |
Additional Paid-In Capital | 1.1% | 755 | 747 | 730 | 704 | 636 | 626 | 624 | 620 | 618 | 614 | 138 | - |
Shares Outstanding | 0.8% | 36.00 | 36.00 | 35.00 | 34.00 | 28.00 | 28.00 | 28.00 | 27.00 | 27.00 | 19.00 | 4.00 | - |
Float | - | - | - | 869 | - | - | - | 310 | - | 236 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 |
Cashflow From Operations | -4.0% | -8,301 | -7,982 | -7,546 | -17,764 | -13,854 | -15,188 | -14,823 | -14,985 | -8,722 | -13,755 | -11,979 | -10,252 | - | - | - |
Share Based Compensation | 8.7% | 4,425 | 4,071 | 3,955 | 3,295 | 2,962 | 2,882 | 2,904 | 2,649 | 2,917 | 2,013 | 1,406 | 1,239 | - | - | - |
Cashflow From Investing | -73.6% | 4,566 | 17,275 | 4,395 | -48,365 | 10,405 | 560 | 43,844 | -14,859 | -35,346 | -80,241 | 19,177 | 14,503 | - | - | - |
Cashflow From Financing | 143.3% | 3,562 | -8,234 | 891 | 65,305 | 6,307 | -455 | 578 | -98.00 | 404 | 120,547 | 10,247 | 6,144 | - | - | - |
Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Income Statement [Abstract] | ||
Revenue from contracts with customers | $ 89,077 | $ 49,005 |
Cost of sales | 35,312 | 27,677 |
Gross profit | 53,765 | 21,328 |
Operating expenses: | ||
Selling, general and administrative | 74,799 | 58,665 |
Research and development | 29,051 | 25,981 |
Total operating expenses | 103,850 | 84,646 |
Loss from operations | (50,085) | (63,318) |
Other income (expense), net: | ||
Interest expense | (3,308) | (4,946) |
Interest and other income | 6,574 | 1,517 |
Loss on extinguishment of term loan | (1,769) | 0 |
Loss before income taxes | (48,588) | (66,747) |
Income tax expense | 20 | 9 |
Net loss | (48,608) | (66,756) |
Other comprehensive income (loss) | ||
Unrealized gain (loss) on short-term investments | 83 | (66) |
Foreign currency translation income (loss) | 7 | (9) |
Total other comprehensive income (loss) | 90 | 75 |
Comprehensive loss | $ (48,518) | $ (66,831) |
Net loss per share: | ||
Attributable to common stock, basic | $ (1.41) | $ (2.41) |
Attributable to common stock, diluted | $ (1.41) | $ (2.41) |
Weighted-average shares outstanding used in computing net loss per share: | ||
Attributable to common stock, basic | 34,455,111 | 27,661,982 |
Attributable to common stock, diluted | 34,455,111 | 27,661,982 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 9,692 | $ 11,834 |
Short-term investments | 117,490 | 93,968 |
Accounts receivable | 20,281 | 10,956 |
Inventories | 17,421 | 14,835 |
Prepaid and other current assets | 3,523 | 2,962 |
Total current assets | 168,407 | 134,555 |
Property and equipment, net | 10,841 | 10,138 |
Operating leases right-of-use assets | 2,444 | 3,943 |
Restricted cash | 711 | 761 |
Other assets | 147 | 767 |
Total assets | 182,550 | 150,164 |
Current liabilities: | ||
Accounts payable | 3,863 | 2,595 |
Accrued expenses and other current liabilities | 15,239 | 12,672 |
Lease liabilities | 1,801 | 1,970 |
Total current liabilities | 20,903 | 17,237 |
Long-term lease liabilities | 1,211 | 2,856 |
Term loan, net | 0 | 40,169 |
Other long-term liabilities | 74 | 0 |
Total liabilities | 22,188 | 60,262 |
Commitments and contingencies (Note 9) | ||
Stockholders' equity: | ||
Common stock, $0.001 par value, 900,000,000 shares authorized, 36,139,513 shares issued and outstanding as of December 31, 2023 and 28,268,389 Shares issued and outstanding as of December 31, 2022 | 36 | 28 |
Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding | 0 | 0 |
Additional paid-in capital | 754,971 | 636,001 |
Accumulated other comprehensive loss | (5) | (95) |
Accumulated deficit | (594,640) | (546,032) |
Total stockholders' equity | 160,362 | 89,902 |
Total liabilities and stockholders' equity | $ 182,550 | $ 150,164 |